MDI Therapeutics
Phase 1MDI Therapeutics is a pharmaceutical company developing novel therapies for the treatment of fibrosis and fibroproliferative diseases.
Founded
2007
Focus
Small Molecules
About
MDI Therapeutics is a pharmaceutical company developing novel therapies for the treatment of fibrosis and fibroproliferative diseases.
Company Info
TypePrivate
Founded2007
LocationCambridge, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile